113 related articles for article (PubMed ID: 22261145)
1. Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in rats.
Crunelle CL; de Wit TC; de Bruin K; Ramakers RM; van der Have F; Beekman FJ; van den Brink W; Booij J
Nucl Med Biol; 2012 Jul; 39(5):640-4. PubMed ID: 22261145
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.
Scherfler C; Scholz SW; Donnemiller E; Decristoforo C; Oberladstätter M; Stefanova N; Diederen E; Virgolini I; Poewe W; Wenning GK
Neuroimage; 2005 Feb; 24(3):822-31. PubMed ID: 15652317
[TBL] [Abstract][Full Text] [Related]
3. Varenicline increases striatal dopamine D(2/3) receptor binding in rats.
Crunelle CL; Miller ML; de Bruin K; van den Brink W; Booij J
Addict Biol; 2009 Sep; 14(4):500-2. PubMed ID: 19650815
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats.
Crunelle CL; Schulz S; de Bruin K; Miller ML; van den Brink W; Booij J
Eur Neuropsychopharmacol; 2011 Feb; 21(2):205-10. PubMed ID: 21130610
[TBL] [Abstract][Full Text] [Related]
5. [123I]Epidepride neuroimaging of dopamine D2/D3 receptor in chronic MK-801-induced rat schizophrenia model.
Huang YR; Shih JM; Chang KW; Huang C; Wu YL; Chen CC
Nucl Med Biol; 2012 Aug; 39(6):826-32. PubMed ID: 22464847
[TBL] [Abstract][Full Text] [Related]
6. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography.
Videbaek C; Toska K; Friberg L; Holm S; Angelo HR; Knudsen GM
J Cereb Blood Flow Metab; 2001 Jan; 21(1):92-7. PubMed ID: 11149673
[TBL] [Abstract][Full Text] [Related]
7. No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeys.
Vermeulen RJ; Drukarch B; Verhoeff NP; Goosen C; Sahadat MC; Wolters EC; van Royen EA; Stoof JC
Synapse; 1994 Jun; 17(2):115-24. PubMed ID: 7916490
[TBL] [Abstract][Full Text] [Related]
8. Dual-radiotracer translational SPECT neuroimaging. Comparison of three methods for the simultaneous brain imaging of D
Tsartsalis S; Tournier BB; Habiby S; Ben Hamadi M; Barca C; Ginovart N; Millet P
Neuroimage; 2018 Aug; 176():528-540. PubMed ID: 29723640
[TBL] [Abstract][Full Text] [Related]
9. High fat/carbohydrate ratio but not total energy intake induces lower striatal dopamine D2/3 receptor availability in diet-induced obesity.
van de Giessen E; la Fleur SE; Eggels L; de Bruin K; van den Brink W; Booij J
Int J Obes (Lond); 2013 May; 37(5):754-7. PubMed ID: 22868829
[TBL] [Abstract][Full Text] [Related]
10. Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans.
Kegeles LS; Zea-Ponce Y; Abi-Dargham A; Rodenhiser J; Wang T; Weiss R; Van Heertum RL; Mann JJ; Laruelle M
Synapse; 1999 Mar; 31(4):302-8. PubMed ID: 10051112
[TBL] [Abstract][Full Text] [Related]
11. Striatal dopamine D2/3 receptor availability increases after long-term bariatric surgery-induced weight loss.
van der Zwaal EM; de Weijer BA; van de Giessen EM; Janssen I; Berends FJ; van de Laar A; Ackermans MT; Fliers E; la Fleur SE; Booij J; Serlie MJ
Eur Neuropsychopharmacol; 2016 Jul; 26(7):1190-200. PubMed ID: 27184782
[TBL] [Abstract][Full Text] [Related]
12. A single-scan protocol for absolute D
Tsartsalis S; Tournier BB; Aoun K; Habiby S; Pandolfo D; Dimiziani A; Ginovart N; Millet P
Neuroimage; 2017 Feb; 147():461-472. PubMed ID: 28011253
[TBL] [Abstract][Full Text] [Related]
13. Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796.
Seibyl JP; Zea-Ponce Y; Brenner L; Baldwin RM; Krystal JH; Offord SJ; Mochoviak S; Charney DS; Hoffer PB; Innis RB
J Nucl Med; 1996 Jan; 37(1):11-5. PubMed ID: 8543979
[TBL] [Abstract][Full Text] [Related]
14. Striatal dopamine D2/D3 receptor availability in male smokers.
Yang YK; Yao WJ; McEvoy JP; Chu CL; Lee IH; Chen PS; Yeh TL; Chiu NT
Psychiatry Res; 2006 Jan; 146(1):87-90. PubMed ID: 16343861
[TBL] [Abstract][Full Text] [Related]
15. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze AL; Möller HJ; Biersack HJ
Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197
[TBL] [Abstract][Full Text] [Related]
16. Correlation between striatal dopamine D2/D3 receptor binding and cardiovascular activity in healthy subjects.
Yeh TL; Yang YK; Chiu NT; Yao WJ; Yeh SJ; Wu JS; Chuang JI; Chang SH
Am J Hypertens; 2006 Sep; 19(9):964-9. PubMed ID: 16942941
[TBL] [Abstract][Full Text] [Related]
17. Striatal D2 receptor binding as a marker of prognosis and outcome in untreated first-episode psychosis.
Corripio I; Pérez V; Catafau AM; Mena E; Carrió I; Alvarez E
Neuroimage; 2006 Jan; 29(2):662-6. PubMed ID: 16112587
[TBL] [Abstract][Full Text] [Related]
18. Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study.
Pogarell O; Koch W; Pöpperl G; Tatsch K; Jakob F; Zwanzger P; Mulert C; Rupprecht R; Möller HJ; Hegerl U; Padberg F
J Psychiatr Res; 2006 Jun; 40(4):307-14. PubMed ID: 16259998
[TBL] [Abstract][Full Text] [Related]
19. GABAergic control of neostriatal dopamine D
Nikolaus S; Beu M; de Souza Silva MA; Huston JP; Antke C; Müller HW; Hautzel H
Pharmacol Biochem Behav; 2017 Feb; 153():76-87. PubMed ID: 28012732
[TBL] [Abstract][Full Text] [Related]
20. Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.
Hierholzer J; Cordes M; Venz S; Schelosky L; Harisch C; Richter W; Keske U; Hosten N; Mäurer J; Poewe W; Felix R
J Nucl Med; 1998 Jun; 39(6):954-60. PubMed ID: 9627325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
